Investor Type | Firm |
Type of Fund | Venture Capital Fund |
Industries | Software (Web Marketplace Saas..) • IT (& TMT) • BioTech • Businesses Solutions • FinTech (& Financials services) • Energy • A.I. (& Big Data) • HealthTech (& Fitness) • Web Security (& Privacy) • Analytics • Cloud Services (& Infrastructure) • Developer tools • Future Of Work • Insurance (& InsurTech) • Medical Devices (& Hospital Services) • Robotics • DeepTech • Healthcare (& Wellness) • Consumer • Pharmaceutical (& Medicine) • Woman Focused |
Stages | Seed, Startup, Early Stage, Series A, Pre-seed |
Investing | United States • United Kingdom • Canada • Singapore • Europe |
Investment Range | $500,000 - $50,000,000 |
Investment Sweet Spot | $2,000,000 |
Assets Under Management | $150,000,000 |
AV8 Ventures is a venture capital firm headquartered in Palo Alto, California, with a second location in London. They focus on backing early-stage startups in a myriad of industries, such as healthcare, enterprise, financial services, deep tech, and other areas including software, IT and TMT, biotech, business solutions, FinTech and financial services, energy, AI and big data, health tech and fitness, web security and privacy, analytics, cloud services and infrastructure, developer tools, future of work, insurance and InsurTech, medical devices and hospital services, robotics, consumer, and pharmaceuticals. With an expertise in equity investments, AV8 Ventures operates with a wide investment range from $500,000 as minimum to a maximum of $5,000,000, considering $1,500,000 as their investment sweet spot. They specialize in various stages of a company's lifecycle, including Seed, Startup, Early Stage, Series A, and Pre-seed funding rounds. The firm manages assets under management totaling approximately $150 million. Their mission is to empower bold entrepreneurial teams by committing early and partnering for the long term to help them build category-defining companies. AV8's portfolio includes companies like Alpha Medical, dedicated to advocating for women’s health; Delfi Diagnostics, which is developing a blood test for early cancer detection; Eclypsium, aimed at protecting devices for distributed workforces and data centers; and Embrace.io, which helps mobile app engineering teams quickly identify and fix bugs.